PL1817065T3 - Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę - Google Patents
Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozęInfo
- Publication number
- PL1817065T3 PL1817065T3 PL05818937T PL05818937T PL1817065T3 PL 1817065 T3 PL1817065 T3 PL 1817065T3 PL 05818937 T PL05818937 T PL 05818937T PL 05818937 T PL05818937 T PL 05818937T PL 1817065 T3 PL1817065 T3 PL 1817065T3
- Authority
- PL
- Poland
- Prior art keywords
- sodium hyaluronate
- preparation
- hydroxypropylmethyl
- cellulose
- solutions containing
- Prior art date
Links
- 229920002385 Sodium hyaluronate Polymers 0.000 title abstract 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 3
- 229940010747 sodium hyaluronate Drugs 0.000 title abstract 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 3
- 239000008154 viscoelastic solution Substances 0.000 title 1
- 239000007943 implant Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000036571 hydration Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0412662A FR2878444B1 (fr) | 2004-11-30 | 2004-11-30 | Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations |
| EP05818937A EP1817065B1 (fr) | 2004-11-30 | 2005-11-28 | Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethylcellulose |
| PCT/FR2005/050996 WO2006059029A2 (fr) | 2004-11-30 | 2005-11-28 | Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethyl- cellulose, preparation et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1817065T3 true PL1817065T3 (pl) | 2011-09-30 |
Family
ID=34952867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05818937T PL1817065T3 (pl) | 2004-11-30 | 2005-11-28 | Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080089918A1 (pl) |
| EP (1) | EP1817065B1 (pl) |
| JP (1) | JP2008521464A (pl) |
| AT (1) | ATE499121T1 (pl) |
| CA (1) | CA2589397C (pl) |
| DE (1) | DE602005026555D1 (pl) |
| DK (1) | DK1817065T3 (pl) |
| ES (1) | ES2364355T3 (pl) |
| FR (1) | FR2878444B1 (pl) |
| PL (1) | PL1817065T3 (pl) |
| WO (1) | WO2006059029A2 (pl) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| EP2152743A2 (en) * | 2007-05-23 | 2010-02-17 | Allergan, Inc. | Cross-linked collagen and uses thereof |
| US20120071437A1 (en) | 2007-07-30 | 2012-03-22 | Allergan, Inc. | Tunable crosslinked polysaccharide compositions |
| US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
| US8697044B2 (en) * | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
| EP3498299A1 (en) | 2007-11-16 | 2019-06-19 | Aclaris Therapeutics, Inc. | Compositions and methods for treating purpura |
| US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
| US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
| US8450475B2 (en) * | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． | ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用 |
| US20110171310A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
| US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
| CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
| HUE030138T2 (en) | 2010-03-22 | 2017-04-28 | Allergan Inc | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| CA2824483C (en) | 2011-01-13 | 2016-08-30 | Allergan, Inc. | Stable hydrogels comprising cross-linked hyaluronic acid and phenylephrine |
| WO2012112757A2 (en) | 2011-02-17 | 2012-08-23 | Allergan, Inc. | Compositions and improved soft tissue replacement methods |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| AU2012262047A1 (en) | 2011-06-03 | 2014-01-16 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| AU2012298791B2 (en) | 2011-08-25 | 2015-09-24 | Allergan Industrie, Sas | Dermal filler compositions including antioxidants |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| KR20220013588A (ko) | 2011-09-14 | 2022-02-04 | 알러간, 인코포레이티드 | 잔주름 치료를 위한 진피 필러 조성물 |
| GB201118586D0 (en) * | 2011-10-27 | 2011-12-07 | Turzi Antoine | New A-PRP medical device, manufacturing machine and process |
| CA2858366C (en) | 2011-12-08 | 2020-01-21 | Allergan Industrie, Sas | Optically transparent dermal filler compositions comprising hyaluronic acid crosslinked with diamines or multiamines |
| EP2874598B1 (en) | 2012-07-18 | 2017-11-22 | Allergan Industrie, SAS | Hyaluronic acid formulation containing pyruvate |
| EP2903588B1 (en) | 2012-10-02 | 2020-02-19 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
| WO2014055895A1 (en) | 2012-10-05 | 2014-04-10 | Allergan, Inc. | Injectable device and method for sculpting, augmenting or correcting facial features such as the chin |
| CA2890056A1 (en) * | 2012-11-02 | 2014-05-15 | Cesacar Participacions, S.L. | Fluorescence coloring for eye surgery |
| CA2893831A1 (en) | 2012-12-07 | 2014-06-12 | Cesacar Participacions, S.L. | Femto second multi shooting for eye surgery |
| WO2015149177A1 (en) | 2014-04-01 | 2015-10-08 | Klox Technologies Inc. | Tissue filler compositions and methods of use |
| WO2016051219A1 (en) | 2014-09-30 | 2016-04-07 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
| KR20170108986A (ko) | 2015-01-28 | 2017-09-27 | 알레간 인코포레이티드 | 관절 지방 패드 제제 및 그의 사용 방법 |
| WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
| EP3653232A1 (en) | 2015-02-13 | 2020-05-20 | Allergan Industrie, SAS | Implants for sculpting, augmenting or correcting facial features such as the chin |
| EP3895742A1 (en) | 2016-10-13 | 2021-10-20 | Allergan, Inc. | Coacervate hyaluronan hydrogels for dermal filler applications |
| WO2020154305A1 (en) | 2019-01-21 | 2020-07-30 | Eclipse Medcorp, Llc | Methods, systems and apparatus for separating components of a biological sample |
| US12007382B2 (en) | 2019-10-31 | 2024-06-11 | Crown Laboratories, Inc. | Systems, methods and apparatus for separating components of a sample |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
| JPS62122671A (ja) * | 1985-11-23 | 1987-06-03 | 千寿製薬株式会社 | 眼内手術用高粘性液の製造法 |
| WO1995007085A1 (en) * | 1993-09-07 | 1995-03-16 | Escalon Ophthalmics, Inc. | Surface active viscoelastic solutions for ocular use |
| WO2003059391A2 (en) * | 2001-12-21 | 2003-07-24 | Alcon, Inc. | Viscoelastics for ocular surgery |
-
2004
- 2004-11-30 FR FR0412662A patent/FR2878444B1/fr not_active Expired - Fee Related
-
2005
- 2005-11-28 WO PCT/FR2005/050996 patent/WO2006059029A2/fr not_active Ceased
- 2005-11-28 DK DK05818937.4T patent/DK1817065T3/da active
- 2005-11-28 PL PL05818937T patent/PL1817065T3/pl unknown
- 2005-11-28 AT AT05818937T patent/ATE499121T1/de active
- 2005-11-28 JP JP2007542074A patent/JP2008521464A/ja active Pending
- 2005-11-28 EP EP05818937A patent/EP1817065B1/fr not_active Expired - Lifetime
- 2005-11-28 ES ES05818937T patent/ES2364355T3/es not_active Expired - Lifetime
- 2005-11-28 US US11/791,603 patent/US20080089918A1/en not_active Abandoned
- 2005-11-28 DE DE602005026555T patent/DE602005026555D1/de not_active Expired - Lifetime
- 2005-11-28 CA CA2589397A patent/CA2589397C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008521464A (ja) | 2008-06-26 |
| WO2006059029A3 (fr) | 2006-08-31 |
| ATE499121T1 (de) | 2011-03-15 |
| EP1817065A2 (fr) | 2007-08-15 |
| US20080089918A1 (en) | 2008-04-17 |
| FR2878444A1 (fr) | 2006-06-02 |
| CA2589397C (en) | 2015-03-31 |
| DE602005026555D1 (de) | 2011-04-07 |
| ES2364355T3 (es) | 2011-08-31 |
| FR2878444B1 (fr) | 2008-04-25 |
| EP1817065B1 (fr) | 2011-02-23 |
| DK1817065T3 (da) | 2011-06-14 |
| CA2589397A1 (en) | 2006-06-08 |
| WO2006059029A2 (fr) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1817065T3 (da) | Viskoelastiske opløsninger indeholdende natriumhyaluronat og hydroxypropylmethylcellulose | |
| GEP20063917B (en) | Pulmonary administration of chemically modified insulin | |
| WO2005082414A3 (en) | Concomitant drugs of a sulfonamide and another therapeutic agent | |
| CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
| BRPI0416986A (pt) | preparação farmacêutica compreendendo um anticorpo contra o receptor de egf | |
| DE60305906D1 (de) | Okklusionszusammensetzung umfassend ein poly(2-cyanoacrylat)-monomer | |
| PT1401501E (pt) | Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo | |
| MXPA05003394A (es) | Conjugados de polimero con antigenicidad disminuida, metodos de preparacion y usos de estos. | |
| MY159203A (en) | Solid preparation comprising alogliptin and metformin hydrochloride | |
| NO20024891L (no) | Farmasöytiske sammensetninger | |
| EP2261236A3 (en) | Composition for proteasome inhibition | |
| WO2007139760A3 (en) | Resorbable polymer compositions for use in medicine, dentistry, and surgery | |
| MY137726A (en) | Freeze-dried pantoprazole preparation and pantoprazole injection | |
| AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| WO2007106142A3 (en) | Process for using optical agents | |
| DK1715900T3 (da) | Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater | |
| SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
| PT1185253E (pt) | Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac | |
| WO2004071374A3 (en) | Once a day orally administered pharmaceutical compositions | |
| DE502005010427D1 (de) | Physiologisch aktive zusammensetzung gegen diabetes | |
| NO20081035L (no) | Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet | |
| WO2006121522A3 (en) | Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions | |
| EP1992350A3 (en) | Medical composition comprising a polysaccharide for elevating the epithelium | |
| NZ523606A (en) | Pharmaceutical compositions and methods for use |